May need further evaluation by a specialistĪre hospital initiated clinical trial materialsĪs for ‘red’ (above) with the addition of the following:ĭesignated by NHS England to require initiation by or in prior agreement with a Specialist Centre.

Require long term on-going monitoring and dose adjustment to ensure efficacy and minimise toxicity by a specialistĭesignated as “hospital only“ by product licence, NICE, DoH or BNF

Require specialist knowledge and/or equipment for patient selection and initiation New drugs which have not as yet been evaluated by the MVGĪny drug not listed in the Buckinghamshire Formularyĭrugs which should only be prescribed in secondary care by a specialist.

Not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.ĭrugs which have been evaluated and rejected by the Medicines Value Group (MVG)ĭrugs defined as ‘Low Priority’ by the South Central Priorities Committee Use with caution in patients with benzodiazepine poisoning, particularly in mixed drug overdoses contraindicated in mixed TCA/benzodiazepine overdose. Reversal of iatrogenic over-sedation with benzodiazepines. The College of Emergency Medicine and NPIS Antidote availability guideline 2017 The details are described in the formulary restriction. Products marked **** need to be obtained from another centre. Products marked *** should be available within 1 hour (ie. Specialist advice on treatment of poisoning is available 24hours from the UK National Poisons Information Service (NPIS) on 08.Īntidote annotation: Products with no asterisk *: should be available immediately in the Emergency Department or any area where poisoned patients are initially treated. Buckinghamshire Formulary Buckinghamshire Healthcare NHS Trustįormulary Chapter 18: Emergency Treatment of Poisoning - Full Chapter

Benzo antidote